This article has been updated from a previous version to clarify pricing information provided by a Quest spokesperson.

NEW YORK (GenomeWeb News) – Industrial giant 3M has thrown its hat into the molecular diagnostics market with the shipment of its first thermal cycler — a compact microfluidics instrument called the 3M Integrated Cycler that Quest Diagnostics subsidiary Focus Diagnostics is marketing with a new line of tests targeted for infectious disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.